Seeking Alpha

BrainsWay Initiates Clinical Evaluation of Rotational Field “Deep TMS 360°™” Technology

BURLINGTON, Mass. and JERUSALEM, Jan. 10, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (BWAY) (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation ...
Seeking Alpha

BrainsWay Launches First Clinical Trial of Deep TMS 360™ System for Alcohol Use Disorder

BURLINGTON, Mass. and JERUSALEM, Nov. 17, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (BWAY) (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation ...
Nasdaq

BrainsWay to Participate in Clinical TMS Society and American Psychiatric Association Meetings

BURLINGTON, Mass. and JERUSALEM, Israel, May 02, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation ...
Yahoo Finance

BrainsWay Champions TMS Education with Sponsorship of Two Free CME Courses for Mental ...

BURLINGTON, Mass. and JERUSALEM, Israel, July 30, 2025 (GLOBE NEWSWIRE) -- BrainsWay, a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, is proud to ...
Yahoo Finance

BrainsWay Receives FDA Clearance of Deep TMS™ as Adjunct Therapy for Major Depressive ...

BURLINGTON, Mass. and JERUSALEM, Israel, Nov. 13, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation ...
Business Insider

BrainsWay Launches First Clinical Trial of Deep TMS 360™ System for Alcohol Use Disorder

BURLINGTON, Mass. and JERUSALEM, Nov. 17, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation ...
Yahoo Finance

BrainsWay to Showcase Deep TMS at the 2025 American Psychiatric Association Annual Meeting ...

BURLINGTON, Mass. and JERUSALEM, May 01, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, ...
Nasdaq

BrainsWay Announces First of its Kind Positive Coverage Policy by Centene for the Treatment ...

CRESSKILL, N.J. and JERUSALEM, May 24, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments ...
News Medical

BrainsWay receives FDA clearance for Deep TMS system to treat adults with obsessive ...

BrainsWay Ltd., the parent company of BrainsWay USA, Inc., and a global leader in the advanced non-invasive treatment of brain disorders, today announces that it has received De Novo clearance from ...